Yatiri Bio, Inc. Deal History & Licensing Activity
Yatiri Bio, Inc. is a life sciences. Over the past three years, Yatiri Bio, Inc. has been involved in 1 licensing and acquisition transaction, with a primary focus on Small Molecules (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Small Molecules
Focus Area
Oncology
Yatiri Bio, Inc. Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Yatiri Bio, Inc. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| denfivontinib (SKI-G-801) | Oscotec, Inc. | Small Molecules | Unknown | option | Mar 2026 |
Yatiri Bio, Inc. Pipeline Focus
Therapeutic areas and modalities where Yatiri Bio, Inc. is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Yatiri Bio, Inc. Strategic Signals
Key indicators of Yatiri Bio, Inc.'s licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
See How Your Asset Matches Yatiri Bio, Inc.'s Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Oncology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Oncology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for oncology
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Yatiri Bio, Inc. Licensing & Deal Activity
Yatiri Bio, Inc. is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Yatiri Bio, Inc. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Yatiri Bio, Inc. include Oncology (2 deals and trials). In terms of modality, Yatiri Bio, Inc. has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Yatiri Bio, Inc. and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Yatiri Bio, Inc.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.